de Vries, Natasja L. (author), van de Haar, Joris (author), Veninga, Vivien (author), Chalabi, Myriam (author), Ijsselsteijn, Marieke E. (author), van der Ploeg, Manon (author), van den Bulk, Jitske (author), Ruano, Dina (author), Wessels, L.F.A. (author) DNA mismatch repair-deficient (MMR-d) cancers present an abundance of neoantigens that is thought to explain their exceptional responsiveness to immune checkpoint blockade (ICB)<sup>1,2</sup>. Here, in contrast to other cancer types<sup>3–5</sup>, we observed that 20 out of 21 (95%) MMR-d cancers with genomic inactivation of β2-microglobulin ...
journal article 2023
